Prelude Therapeutics Incorporated
Prelude Therapeutics Incorporated scores highest on Anchor (55) and lowest on Price (30). Its PosiPenta is 46.49 out of 100, around the middle of similar companies.
On the Penta Grid this week, Prelude Therapeutics Incorporated is Grid #355 of 837 in the Healthcare sector in United States, and Grid #2,275 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Prelude Therapeutics Incorporated | 46.49 | 30 | 47 | 54 | 46 | 55 |
| Century Therapeutics, Inc. | 47.01 | 39 | 54 | 51 | 47 | 44 |
| Vogenx, Inc. | 48.79 | 0 | 70 | 33 | 95 | 45 |
| Anika Therapeutics, Inc. | 64.30 | 29 | 83 | 89 | 59 | 61 |
| ClearPoint Neuro, Inc. | 23.73 | 2 | 34 | 28 | 9 | 46 |
| InfuSystem Holdings, Inc. | 58.99 | 33 | 61 | 95 | 60 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -4.47 |
| P/B ratio | 1.95 |
EEarnings
| Trailing EPS | ₹-69.14 |
| Forward EPS | ₹-52.10 |
NNitro
| Price | 308.77 |
| 52-week high | 646.90 |
| 52-week low | 109.87 |
| Fall from 52-week high | 52.3% |
TTorque
| Return on equity (ROE) | -57.73% |
| Debt-to-equity | 0.13 |
AAnchor
| Beta (price swings) | 0.96 |
| Market cap | ₹2,464 Cr |
| Insider holding | 13.76% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Prelude Therapeutics Incorporated's PosiPenta score?
Prelude Therapeutics Incorporated's PosiPenta is 46.49 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Prelude Therapeutics Incorporated stand on the Penta Grid?
On the Penta Grid this week, Prelude Therapeutics Incorporated is Grid #355 of 837 in the Healthcare sector in United States, and Grid #2,275 of 4,000 in United States.
Which PosiPenta pillar is strongest for Prelude Therapeutics Incorporated?
Anchor (stability and dividends), with a score of 55 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Prelude Therapeutics Incorporated?
Price (valuation), with a score of 30 out of 100: weaker than most similar companies.
Has Prelude Therapeutics Incorporated's PosiPenta changed since last week?
Yes, it rose 3.34 points, from 43.15 to 46.49.
PositoAI is for research and education only and is not investment advice.